Panelists discuss how to effectively diagnose and manage chronic spontaneous urticaria, highlighting the importance of personalized treatment approaches and the exploration of emerging therapies to improve patient outcomes.
EP. 1: Overview of CSU: Prevalence and Presentations
October 25th 2024Panelists discuss the prevalence and clinical manifestations of chronic spontaneous urticaria (CSU), noting that it primarily affects individuals aged 20 to 40, with a prevalence of 0.5% to 1% in the general population and a higher incidence in women, while also addressing the variability in symptoms such as wheals, hives, and angioedema among patients.
EP. 2: Impact of CSU on Patient Quality of Life
October 25th 2024Panelists discuss how chronic spontaneous urticaria (CSU) significantly impacts patients’ overall well-being, both clinically and psychosocially, highlighting increased prevalence of depression, sleep disturbances, absenteeism, and adverse effects on professional life.